Pings in users from the Schistosoma mansoni venom allergen-like (SmVAL) gene household. BMC Genomics. 2008;9:89. Hillyer GV, del Llano de Diaz A, Reyes CN. Schistosoma mansoni: acquired immunity in mice and hamsters applying antigens of Fasciola hepatica. Exp Parasitol. 1977;42(2):348?five. Hillyer GV, Garcia Rosa MI, Alicea H, Hernandez A. Prosperous vaccination from murine Schistosoma mansoni infection having a purified twelve Kd Fasciola hepatica cross-reactive antigen. Am J Trop Med Hyg. 1988;38(one):103?0. Moser D, Tendler M, Griffiths G, Klinkert MQ. A 14-kDa Schistosoma mansoni polypeptide is homologous into a gene household of fatty acid PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/6388955 binding proteins. J Biol Chem. 1991;266(13):8447?4.83. Tendler M, Brito CA, Vilar MM, Serra-Freire N, Diogo CM, Almeida MS, et al. A Schistosoma mansoni fatty acid-binding protein, Sm14, is definitely the possible foundation of the dual-purpose anti-helminth vaccine. Proc Natl Acad Sci U S A. 1996;93(1):269?3. 84. Abane JL, Oleaga A, Ramajo V, Casanueva P, Arellano JL, Hillyer GV, et al. Vaccination of mice in opposition to Schistosoma bovis having a recombinant fatty acid binding protein from Fasciola hepatica. Vet Parasitol. 2000;91(one?):33?two. eighty five. El Ridi R, Tallima H. Vaccine-induced security against murine schistosomiasis mansoni with larval excretory-secretory antigens and papain or type-2 cytokines. J Parasitol. 2013;ninety nine(2):194?02. 86. Sokol CL, Medzhitov R. Function of basophils within the initiation of Th2 responses. Curr Opin Immunol. 2010;22(one):seventy three?. 87. El Ridi R, Tallima H, Selim S, Donnelly S, Cotton S, Gonzales Santana B, et al. Cysteine peptidases as schistosomiasis vaccines with inbuilt adjuvanticity. PLoS Just one. 2014;nine(one), e85401. 88. Kariuki TM, Farah IO, Yole DS, Mwenda JM, Van Dam GJ, Deelder AM, et al. Parameters from the attenuated schistosome vaccine evaluated in the olive baboon. Infect Immun. 2004;seventy two(nine):5526?. 89. Boulanger D, Reid 15-Deoxy-Δ-12,14-prostaglandin J2 GD, Sturrock RF, Wolowczuk I, Balloul JM, Grezel D, et al. Immunization of mice and baboons using the recombinant Sm28GST affects both of those worm viability and fecundity after experimental an infection with Schistosoma mansoni. Parasite Immunol. 1991;thirteen(5):473?0. ninety. Soisson LA, Reid GD, Farah IO, Nyindo M, Strand M. Protecting immunity in baboons vaccinated with a recombinant antigen or radiation-attenuated cercariae of Schistosoma mansoni is antibody-dependent. J Immunol. 1993; 151(nine):4782?. 91. Carvalho-Queiroz C, Nyakundi R, Ogongo P, Rikoi H, Egilmez NK, Farah IO, et al. Protecting opportunity of antioxidant enzymes as vaccines for schistosomiasis inside a non-human primate product. Front Immunol. 2015;6:273. ninety two. Zhang W, Ahmad G, Torben W, Noor Z, Le L, Damian RT, et al. Sm-p80based DNA vaccine presents baboons with concentrations of safety against Schistosoma mansoni an infection comparable to people obtained because of the irradiated cercarial vaccine. J Infect Dis. 2010;201(seven):1105?two. ninety three. Ahmad G, Zhang W, Torben W, Ahrorov A, Damian RT, Wolf RF, et al. Preclinical prophylactic efficacy screening of Sm-p80-based vaccine inside of a nonhuman primate product of Schistosoma mansoni an infection and immunoglobulin G and E responses to Sm-p80 in human serum samples from a place where by schistosomiasis is endemic. J Infect Dis. 2011;204(9):1437?nine. 94. Ho YH. On th host specificity of Schistosoma japonicum. Chin Med J. 1963; eighty two(seven):403?4. ninety five. Xiao SH, Mei JY, Jiao PY. Schistosoma japonicum-infected hamsters (Mesocricetus auratus) utilised as being a product in experimental chemotherapy with praziquantel, artemether, and OZ compounds. Parasitol Res. 2011;108(2):4.
For more info on 15-Deoxy-Δ-12,14-prostaglandin J2 look at our page.